3. 関節内および軟部組織注射:注射剤の種類および投与頻度 intraarticular and soft tissue injections what agents to inject and how frequently
4. 膵外分泌癌の臨床症状、診断、および病期分類 clinical manifestations diagnosis and staging of exocrine pancreatic cancer
5. 薬剤誘発性の弁膜症 valvular heart disease induced by drugs
Japanese Journal
19-ノルテストステロン誘導体の並行投与された発情ホルモンに対する諸効果
前川 久太郎,伊藤 羽衣子,池田 義隆
動物学雑誌 68(9), 335-340, 1959-09-15
… 1) Adequate daily doses of 19-nortestosterone derivatives having progestational property, 17α-ethinyl-19-nortestosterone (2 mg or more daily) and 17α-methyl-19-nortestosterone (0.5 mg or more daily), were capable of suppressing the vaginal cornifying action of estrone administered simultaneously. … 2) Progestational property of 17α-ethinyl-19-nortestosterone interfered with estrogenic action of its own, if administered 2.0 mg or more daily (Maekawa, '59). …